Erasca, Inc. (ERAS) vs Travere Therapeutics, Inc. (TVTX)
Erasca, Inc. and Travere Therapeutics, Inc. are both Biotechnology companies. Travere Therapeutics, Inc. is the larger, with a market value of $5.7B against $5.1B — 1.1× the size. Erasca, Inc. has the higher net margin (0.00% vs −7.35%) and the lower return on invested capital (−203.1% vs −18.3%). Across the 14 metrics below, Erasca, Inc. leads on 7 and Travere Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | ERAS | TVTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 98.60% | 65.16% |
| Operating margin | 0.00% | (6.84%) | 0.00% |
| Net margin | 0.00% | (7.35%) | 0.00% |
| Free cash flow margin | 0.00% | 2.56% | 0.00% |
| Return on equity | (78.25%) | (151.79%) | (57.72%) |
| Return on assets | (65.25%) | (6.42%) | (49.22%) |
| Return on invested capital | (203.13%) | (18.31%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack